Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-03-11

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $146.03 per share (Direct)
  Date: 2026-03-11 | Code: M | equity_swap_involved: false | shares_owned_after: 9,630.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 360 shares of Common Stock at $532.1278 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: false | shares_owned_after: 9,270.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 240 shares of Common Stock at $533.4667 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: false | shares_owned_after: 9,030.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 824 shares of Common Stock at $535.8159 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: false | shares_owned_after: 8,206.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,215 shares of Common Stock at $536.9468 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: false | shares_owned_after: 6,991.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 1,106 shares of Common Stock at $538.0113 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: false | shares_owned_after: 5,885.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,095 shares of Common Stock at $538.923 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: false | shares_owned_after: 4,790.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 840 shares of Common Stock at $540.0685 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: false | shares_owned_after: 3,950.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 942 shares of Common Stock at $541.0449 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: false | shares_owned_after: 3,008.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 1,178 shares of Common Stock at $542.1312 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: false | shares_owned_after: 1,830.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 240 shares of Common Stock at $543.0352 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: false | shares_owned_after: 1,590.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Sold 1,160 shares of Common Stock at $544.2032 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: false | shares_owned_after: 430.00 | transaction_form_type: 4 | Footnotes: F1, F12
• Sold 300 shares of Common Stock at $544.7613 per share (Direct)
  Date: 2026-03-11 | Code: S | equity_swap_involved: false | shares_owned_after: 130.00 | transaction_form_type: 4 | Footnotes: F1, F13
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 324,518.00 | Footnotes: F14
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 258,117.00 | Footnotes: F15
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F16
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 10,962.00 | Footnotes: F17
• Sold 9,500 shares of Stock Option at $146.03 per share (Derivative)
  Date: 2026-03-11 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | shares_owned_after: 164,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.
• F2: This transaction was executed in multiple trades at prices ranging from $531.90 to $532.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $533.04 to $533.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $535.42 to $536.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $536.44 to $537.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $537.46 to $538.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $538.46 to $539.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $539.52 to $540.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $540.56 to $541.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F10: This transaction was executed in multiple trades at prices ranging from $541.56 to $542.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $542.64 to $543.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: This transaction was executed in multiple trades at prices ranging from $543.66 to $544.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F13: This transaction was executed in multiple trades at prices ranging from $544.68 to $544.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F14: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F15: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F16: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F17: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.